Scrip’s Five Must-Know Things – 19 December 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: first ever gene editing FDA nod; US FTC ruffles pharma’s feathers; AstraZeneca pays to play in RSV; Syndax leukemia drug makes splash at ASH; BMS bets big on Chinese ADC. https://scrip.citeline.com/SC149527/Quick-Listen-Scrips-Five-MustKnow-Things